We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
ClinicalTrials.gov Menu

Vorinostat Plus Hydroxychloroquine Versus Regorafenib in Colorectal Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02316340
Recruitment Status : Completed
First Posted : December 12, 2014
Last Update Posted : April 10, 2020
Information provided by (Responsible Party):
The University of Texas Health Science Center at San Antonio

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
Recruitment Status : Completed
Actual Primary Completion Date : March 7, 2018
Actual Study Completion Date : April 16, 2018
Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 August 25, 2020
September 16, 2020
2 December 11, 2020
January 6, 2021
3 May 25, 2021
June 17, 2021
4 December 13, 2021
January 12, 2022
5 May 4, 2022
June 1, 2022